Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30297390 | 1.00 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL5520472 | 1.00 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL5520469 | 1.00 | TSHR (0.48) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL13194768 | 0.92 | TSHR (0.42) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL8744116 | 0.92 | HTT (0.46) | TSHRMEN1THRBHTTKMT2A | |
| SCHEMBL8482915 | 0.89 | THRB (0.50) | TSHRMEN1THRBHTTKMT2A | |
| SCHEMBL8482916 | 0.89 | THRB (0.50) | TSHRMEN1THRBHTTKMT2A | |
| SCHEMBL5440335 | 0.88 | TSHR (0.50) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL18328170 | 0.88 | TSHR (0.39) | TSHRADRB2ADRB1ADRB3CYP3A4 | |
| SCHEMBL13889961 | 0.88 | TSHR (0.50) | TSHRADRB2ADRB1ADRB3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9713808-B2 | Highly Z-selective olefin metathesis | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-07-25 | — | — | US | disclosed |
| US-20170113984-A1 | HIGHLY Z-SELECTIVE OLEFIN METATHESIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-04-27 | — | — | US | disclosed |
| US-9403854-B2 | Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160008802-A1 | HIGHLY Z-SELECTIVE OLEFIN METATHESIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-14 | — | — | US | disclosed |
| US-9096519-B2 | Process for the synthesis of ketones from internal alkenes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-08-04 | — | — | US | disclosed |
| US-9079173-B2 | Highly Z-selective olefins metathesis | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140288319-A1 | CROSS-METATHESIS REACTION OF FUNCTIONALIZED AND SUBSTITUTED OLEFINS USING GROUP 8 TRANSITION METAL CARBENE COMPLEXES AS METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140194604-A1 | PROCESS FOR THE SYNTHESIS OF KETONES FROM INTERNAL ALKENES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-07-10 | — | — | US | disclosed |
| US-20130274482-A1 | HIGHLY Z-SELECTIVE OLEFINS METATHESIS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2013-10-17 | — | — | US | disclosed |
| EP-1497299-B1 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2012-06-27 | — | — | EP | disclosed |
| US-20110130559-A1 | Methods to Manufacture 1,3-Dioxolane Nucleosides | GILEAD SCIENCES, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| US-7785839-B2 | Methods to manufacture 1,3-dioxolane nucleosides | EMORY UNIVERSITY (US) | 2010-08-31 | — | — | US | disclosed |
| US-20090012120-A1 | Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2009-01-08 | — | — | US | disclosed |
| US-20070155975-A1 | Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170113984-A1 | HIGHLY Z-SELECTIVE OLEFIN METATHESIS | ZDHHC2, ZDHHC7, JUN | TSHR 4678/4885ADRB2 1654/4885ADRB1 2116/4885 |
| US-20140288319-A1 | CROSS-METATHESIS REACTION OF FUNCTIONALIZED AND SUBSTITUTED OLEFINS USING GROUP 8 TRANSITION METAL CARBENE COMPLEXES AS METATHESIS CATALYSTS | OXER1, OSTC, OXSR1 | TSHR 2555/4885ADRB2 1501/4885ADRB1 2844/4885 |
| US-20070155975-A1 | Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts | OXER1, OSTC, OXSR1 | TSHR 2555/4885ADRB2 1501/4885ADRB1 2844/4885 |
| US-20090012120-A1 | Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines | TET1, TET3, TET2 | TSHR 2408/4885ADRB2 1654/4885ADRB1 2300/4885 |
| US-20140194604-A1 | PROCESS FOR THE SYNTHESIS OF KETONES FROM INTERNAL ALKENES | FASN, NOTUM, DGAT2 | TSHR 4198/4885ADRB2 1667/4885ADRB1 1841/4885 |
| US-20110130559-A1 | Methods to Manufacture 1,3-Dioxolane Nucleosides | DCTD, AMPD1, DAD1 | TSHR 3705/4885ADRB2 3370/4885ADRB1 2074/4885 |
| US-20160008802-A1 | HIGHLY Z-SELECTIVE OLEFIN METATHESIS | ZDHHC2, ZDHHC7, JUN | TSHR 4678/4885ADRB2 1654/4885ADRB1 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.